最新整形外科技術、インプラント、再生医療用品市場

Abstract

INTRODUCTION

With technology advancements and a better understanding of the body, the orthopedic device market offers a range of highly complex and leading-edge products. They now are a significant part of the industry. While there are many conventional and generally less expensive products, new items and biotechnological advancements are beginning to revolutionize future growth of the orthopedic device market. The latest technological products are competing in a fast track market that looks to improve the quality of life for millions of individuals who need procedures such as hip and knee transplants.

Ongoing patient management studies, combined with a drive to produce technologically superior products, will increase the number of patients who can benefit from developments in the advanced orthopedic product market. This study will provide readers with the knowledge needed to adequately view and assess this market and will provide insights into the market potentials, including trends that are, and will continue to drive this segment in the future.

SCOPE OF STUDY

This report:

• Provides a complete U.S. and global market analysis
• Quantifies all major markets, including bone repair and regenerative products, cartilage repair and regenerative products, joint replacements, implants and regenerative products, tissue repair and regenerative products, and others
• Analyzes key market drivers such as insurance and reimbursement issues, marketing and advertising issues and trends, world demographics, the trends in orthopedic disability and evolving lifestyles trends, orthopedic-device related infections and much more
• Includes industry overview, development of the advanced orthopedic market, regulation and classification of devices by region
• Analyzes markets by product type, competitor analysis and supplier strategy, research and development, patent analysis, and company profiles are all included in this comprehensive volume.

METHODOLOGY

The information for this report was obtained through primary and secondary data collection methods. Primary sources included interviews with more than 50 key executives, product managers, clinical specialists and other related key personnel involved with the wound care industry. Secondary sources included published literature, investment reports, company literature, and various business journals that have emphases on orthopedic devices and related areas.

Market data for this report pertains to the world market in U.S. dollars at the manufacturers' level. The base year of the report is 2006, with historical data provided for 2005, and forecast data provided for 2007 and 2012. Historical, base year, and forecast data are provided for each market segment of the report. Growth rates are determined through a compilation of data including past trends, future trends, demographics, incidence, mortality, products in research and development, current product growth, etc. Competitor market share estimates are provided for each market segment for the 2006 base year

ANALYST' S CREDENTIALS

Melissa Elder is an experienced healthcare market analyst specializing in prescription and over-the-counter pharmaceuticals. Ms. Elder has more than 13 years' experience in the healthcare industry, specializing in market research for the past 10 years. This experience has given her substantial insights into pharmaceutical market analysis. Her work in the medical community, including emergency room medical training and healthcare information system coordination, has enhanced her ability to provide insight into many healthcare markets.

Table of Contents

• INTRODUCTION
  • STUDY GOALS AND OBJECTIVES
  • REASONS FOR DOING THE STUDY
  • SCOPE OF THE REPORT
  • METHODOLOGY
  • RELATED BCC STUDIES
  • ANALYST CREDENTIALS
  • BCC RESEARCH ONLINE SERVICES
  • DISCLAIMER
• SUMMARY
  • Summary Table:
  • ADVANCED ORTHOPEDIC TECHNOLOGY, IMPLANTS, AND REGENERATIVE PRODUCTS, THROUGH 2012 ($ MILLIONS)
  • Summary Figure:
  • ADVANCED ORTHOPEDIC TECHNOLOGY, IMPLANTS AND REGENERATIVE PRODUCTS, THROUGH 2012 ($ MILLIONS)
• INDUSTRY OVERVIEW
  • HISTORY OF THE ORTHOPEDIC INDUSTRY
    • ADVANCED ORTHOPEDIC MARKET DEVELOPMENT
    • GOVERNMENT REGULATION OF DEVICES
      • Regulation, Cost and Classification of Devices by Region
        • Costs
• Figure 1 STANDARD SUBMISSION FEES AND EXPENDITURES FOR DEVICE APPROVALS PER COUNTRY (U.S. DOLLARS)
  • United States (FDA)
    • 510(k) Exemptions
• Table 1 PARTS 862-892 OF 21 CFR
  • Humanitarian Device Exemption (U.S.)
  • Investigational Device Exemption (IDE)
  • Changes in FDA Advisor Roles
• Canada (Health Canada)
• Europe (MDD)
  • Europe (MDD) (Continued)
• Japan
• Australia
• TREATMENT SETTINGS
  • Ambulatory Treatment Facilities
• Table 2 AMBULATORY VISITS ALL AGES, 1994 AND 2004
• Table 3 AMBULATORY VISITS PER PERSON ALL AGES, 1994 AND 2004
  • Orthopedic Rehabilitation Facilities and Physical Therapy
• ISSUES AFFECTING THE MARKET
  • Insurance and Reimbursement Issues
• Table 4 ANNUAL HEALTH EXPENDITURES AS A PERCENT OF GROSS DOMESTIC PRODUCT (GDP) BY COUNTRY, 2005 ESTIMATES ($ THOUSANDS)
• Figure 2 ANNUAL HEALTH EXPENDITURES AS A PERCENT OF GROSS DOMESTIC PRODUCT (GDP) BY COUNTRY, 2005 ESTIMATES ($ THOUSANDS)
  • Marketing and Advertising Issues and Trends
• LEADING MANUFACTURERS' STRATEGIES
  • Manufacture, Distribution and Supply
• Table 5 ADVANCED ORTHOPEDIC MANUFACTURING AND SUPPLY FACILITIES
  • Manufacture, Distribution ... (Continued)
• Sales and Marketing
• Table 6 ADVANCED ORTHOPEDIC SALES, MARKETING AND ADMINISTRATIVE EXPENDITURES BY MANUFACTURER FOR FISCAL YEAR 2006 ($ MILLIONS)
• Figure 3 ADVANCED ORTHOPEDIC SALES, MARKETING AND ADMINISTRATIVE EXPENDITURES BY MANUFACTURER FOR FISCAL YEAR 2006 ($ MILLIONS)
  • Sales and Marketing (Continued)
• Medical Tourism Impact on the Orthopedic Market
• Table 7 HIP REPLACEMENT: WORLDWIDE COST VARIATIONS
• Figure 4 HIP REPLACEMENT: WORLDWIDE COST VARIATIONS
• Table 8 U.S. HEALTH INSURANCE COVERAGE BY AGE GROUP (%)
• Figure 5 U.S. HEALTH INSURANCE COVERAGE BY AGE GROUP (%)
• Table 9 WORLD HEALTH ORGANIZATION RANKING OF HEALTHCARE SYSTEMS, TOP 50
  • WORLD DEMOGRAPHICS
• Table 10 ESTIMATED WORLD POPULATION BY AGE GROUP, 2005-2012 (MILLIONS)
• Figure 6 ESTIMATED WORLD POPULATION BY AGE GROUP, 2005-2012 (MILLIONS)
• Table 11 ESTIMATED WORLD POPULATION, BY REGION, 2005-2012 (MILLIONS)
• Figure 7 ESTIMATED WORLD POPULATION BY REGION, THROUGH 2012 (MILLIONS)
• Table 12 U.S. POPULATION ESTIMATES AND PROJECTIONS BY AGE GROUP FOR THE SPECIFIC YEARS, 1900-2050 (THOUSANDS)
• Figure 8 U.S. POPULATION ESTIMATES AND PROJECTIONS BY AGE GROUP FOR THE SPECIFIC YEARS, 1900-2050 (THOUSANDS)
  • Gender and Age
• Table 13 LIFE EXPECTANCY IN THE U.S. AT BIRTH AND PROJECTIONS BY SEX, 2002-2011 (AVERAGE NUMBER OF YEARS)
• Figure 9 LIFE EXPECTANCY IN THE U.S. AT BIRTH AND PROJECTIONS, BY SEX, 2000-2011 (AVERAGE NUMBER OF YEARS)
  • Incidence of Orthopedic Conditions
    • Osteoarthritis
    • Rheumatoid Arthritis
    • Ankylosing Spondylitis
    • Fibromyalgia
    • Gout
    • Scleroderma
    • Lupus
    • Bursitis and Tendonitis
    • Osteoporosis
    • Low Bone Mass
• Table 14 ESTIMATED* PREVALENCE/INCIDENCE OF CONDITIONS AFFECTING THE WORLDWIDE ORTHOPEDIC INDUSTRY
• Figure 10 ESTIMATED* PREVALENCE/INCIDENCE OF CONDITIONS AFFECTING THE WORLDWIDE ORTHOPEDIC INDUSTRY (%)
  • Orthopedic Procedure Volumes in the United States
• Figure 11 NUMBER OF U.S. HIP REPLACEMENT PROCEDURES, 2000-2006 (THOUSANDS)
• Figure 12 NUMBER OF U.S. KNEE REPLACEMENT PROCEDURES, 2000-2006 (THOUSANDS)
• Figure 13 NUMBER OF U.S. SPINAL FUSION PROCEDURES, 2000-2006 (THOUSANDS)
• Figure 13 (CONTINUED)
• Figure 14 NUMBER OF U.S. PHYSICIAN VISITS FOR ROTATOR CUFF PROBLEMS, 2000-2006 (MILLIONS)
  • Rising Orthopedic Incidence and Evolving Lifestyle Trends
• Table 15 U.S. AGE-ADJUSTED PERCENT DISTRIBUTION OF BODY MASS INDEX (BMI) AMONG PERSONS 18 YEARS AND OVER BY SELECTED CHARACTERISTICS, 2003
• Figure 15 OBESITY PERCENTAGES BY COUNTRY, 2005
• Table 16 PERCENT OF SMOKERS IN THE U.S. POPULATION 18 AND OLDER BY AGE AND SEX, 2003 (%)
• Table 17 PERCENT OF U.S. ADULTS ENGAGING IN LEISURE-TIME, TRANSPORTATION-RELATED AND HOUSEHOLD-RELATED PHYSICAL ACTIVITY1 BY SELECTED CHARACTERISTICS, 2003 (%)
  • Comparison of Bone Mineral Density Levels
    • Comparison of Bone Mineral ... (Continued)
• TECHNOLOGY
  • INTRODUCTION
  • WORLD PATENT TRENDS
• Table 18 ADVANCED ORTHOPEDIC PATENTS FILED WORLDWIDE BY YEAR, 1992-2006
• Figure 16 ADVANCED ORTHOPEDIC PATENTS FILED WORLDWIDE BY YEAR, 1992-2006
  • PATENT TRENDS BY COUNTRY
• Table 19 WORLDWIDE ADVANCED ORTHOPEDIC PATENTS BY COUNTRY THROUGH 2006
• Figure 17 WORLDWIDE ADVANCED ORTHOPEDIC PATENTS BY COUNTRY THROUGH 2006 (%)
  • PATENT TRENDS BY ASSIGNEE
• Table 20 ADVANCED ORTHOPEDIC PATENT INFORMATION FOR LEADING COMPANIES
• Table 20 (CONTINUED)
• Table 20 (CONTINUED)
• Table 20 (CONTINUED)
• Table 20 (CONTINUED)
• Table 20 (CONTINUED)
• Table 20 (CONTINUED)
• Figure 18 ADVANCED ORTHOPEDIC PATENTS HELD BY LEADING COMPANIES
  • Patent Trends by Assignee (Continued)
  • Patent Trends by Assignee (Continued)
• EMERGING TECHNOLOGY AREAS
  • Nanotechnology and Microprocessors
  • Digital X-rays
  • Bone Density Improvements
  • High-resolution Cartilage Imaging
  • Stem Cells
    • Government Limitations
    • Embryonic Stem Cells
    • Adult Stem Cells
    • New Stem Cell Findings
    • Bone Technology and Stem Cells
  • Synthetic Bone Grafting Technology
  • Bone Modeling for Osteoporotic Spinal Fracture Testing
  • Advanced Mechanical Implant Creation
• CURRENT TECHNOLOGY USES
  • Bone Growth Stimulators
  • TENS Units
  • LED Therapy
  • Light-emitting Diodes with Infrared Lasers
  • Thermal Imaging
• BONE REPAIR AND REGENERATIVE PRODUCTS
  • Bone Grafts
• Table 21 BONE GRAFT PRODUCTS AND MATERIALS
  • Procedures Using Bone Grafts
• PRODUCT DESCRIPTIONS
  • Allografts/ autografts
• Table 22 BONE ALLOGRAFT/ AUTOGRAFT PRODUCTS AND COMPETITORS
  • Allografts/ Autografts (Continued)
  • Bone Growth Stimulators
• Table 23 BONE GROWTH STIMULATOR PRODUCTS AND COMPETITORS
  • Bone Growth Stimulators (Continued)
  • Bone Growth Stimulators (Continued)
• Synthetic Bone Replacements
• Table 24 SYNTHETIC BONE REPLACEMENT PRODUCTS AND COMPETITORS
  • Synthetic Bone Replacements (Continued)
  • Synthetic Bone Replacements (Continued)
• NEW PRODUCT DEVELOPMENTS
• MARKET ANALYSIS
  • Markets by Product Type
    • Markets by Product Type (Continued)
• Table 25 GLOBAL BONE REPAIR AND REGENERATIVE PRODUCTS MARKET FORECAST, THROUGH 2012 ($ MILLIONS)
• Figure 19 GLOBAL BONE REPAIR AND REGERATIVE PRODUCTS MARKET FORECAST 2005-2012 ($ MILLIONS)
  • MARKETS BY WORLD REGION
• Table 26 REVENUE DISTRIBUTION FOR BONE REPAIR AND REGENERATIVE PRODUCTS BY WORLD REGION, 2006
• Figure 20 REVENUE DISTRIBUTION FOR BONE REPAIR AND REGENERATIVE PRODUCTS BY WORLD REGION, 2006 (%)
  • Leading Suppliers and Participants
    • Leading Suppliers and ... (Continued)
• Table 27 SUMMARY OF BONE REPAIR AND REGENERATIVE PRODUCTS BY COMPETITOR REVENUES, 2006 ($ MILLIONS)
• Figure 21 SUMMARY OF BONE REPAIR AND REGENERATIVE PRODUCTS BY COMPETITOR REVENUES, 2006 (%)
  • CARTILAGE AND OTHER SOFT TISSUE REPAIR AND REGENERATIVE PRODUCTS
    • Product Descriptions
      • Fixation Systems and Other Specialized Devices
• Table 28 FIXATION SYSTEMS AND OTHER SPECIALIZED DEVICES AND MARKETERS
• Table 28 (CONTINUED)
  • Fixation Systems and ... (Continued)
  • Biologics and Biomaterials
• Table 29 CARTILAGE AND SOFT TISSUE BIOLOGICS AND BIOMATERIALS SEGMENT
  • New Product Developments
• MARKET ANALYSIS
  • Markets by Product Type
• Table 30 CARTILAGE AND OTHER SOFT TISSUE REPAIR AND REGENERATIVE PRODUCTS MARKET, THROUGH 2012 ($ MILLIONS)
• Figure 22 CARTILAGE AND OTHER SOFT TISSUE REPAIR AND REGENERATIVE PRODUCTS MARKET, 2005-2012 ($ MILLIONS)
  • Markets by World Region
• Table 31 WORLDWIDE DISTRIBUTION OF REVENUES FROM CARTILAGE AND OTHER SOFT TISSUE REPAIR AND REGENERATIVE PRODUCTS BY REGION, 2006 (%)
• Figure 23 WORLDWIDE DISTRIBUTION OF REVENUES FROM CARTILAGE AND OTHER SOFT TISSUE REPAIR AND REGENERATIVE PRODUCTS BY REGION, 2006 (%)
  • Leading Suppliers and Participants
• Table 32 SUMMARY OF CARTILAGE AND OTHER SOFT TISSUE REPAIR AND REGENERATIVE PRODUCTS BY COMPETITOR REVENUES, 2006 ($ MILLIONS)
• Figure 24 SUMMARY OF CARTILAGE AND OTHER SOFT TISSUE REPAIR AND REGENERATIVE PRODUCTS BY COMPETITOR REVENUES, 2006 (%)
• JOINT REPLACEMENTS, IMPLANTS AND REGENERATIVE PRODUCTS
  • Joint Replacements, Implants ...(Continued)
  • Joint Replacements, Implants ...(Continued)
  • Product Description
    • Hip Replacements
• Table 33 HIP REPLACEMENT PRODUCTS AND COMPETITORS
• Table 33 (CONTINUED)
• Table 33 (CONTINUED)
  • Hip Replacements.(continued)
  • Hip Replacements.(continued)
  • Hip Replacements.(continued)
• Knee Replacements
• Table 34 KNEE REPLACEMENT PRODUCTS AND COMPETITORS
• Table 34 (CONTINUED)
  • Knee Replacements (Continued)
  • Knee Replacements (Continued)
• Spine Replacements
• Table 35 SPINE REPLACEMENT PRODUCTS AND COMPETITORS
• Table 35 (CONTINUED)
• Table 35 (CONTINUED)
  • Spine Replacements (Continued)
  • Spine Replacements (Continued)
• Other Extremity Replacements and Joint Products
• Table 36 OTHER EXTREMITY REPLACEMENTS, JOINT PRODUCTS AND COMPETITORS
• Table 36 (CONTINUED)
  • Other Extremity ... (Continued)
• Biological Joint Products and Other Related Devices
• Table 37 BIOLOGICAL JOINT PRODUCTS AND OTHER RELATED DEVICES
  • Biological Joint ... (Continued)
• New Product Developments
  • MARKET ANALYSIS
    • Markets by Product Type
      • Markets by Product ... (Continued)
• Table 38 GLOBAL JOINT REPLACEMENT, IMPLANT AND REGENERATIVE PRODUCT MARKET FORECASTS, THROUGH 2012 ($ MILLIONS)
• Figure 25 GLOBAL JOINT REPLACEMENT, IMPLANT AND REGENERATIVE PRODUCT MARKET FORECASTS, THROUGH 2012 ($ MILLIONS)
  • Markets by World Regions
• Table 39 WORLDWIDE REVENUE DISTRIBUTION FOR JOINT REPLACEMENTS, IMPLANTS AND REGENERATIVE PRODUCTS, 2006 (%)
• Figure 26 WORLDWIDE REVENUE DISTRIBUTION FOR JOINT REPLACEMENTS, IMPLANTS AND REGENERATIVE PRODUCTS, 2006 (%)
  • LEADING SUPPLIERS AND PARTICIPANTS
  • Leading Suppliers ... (Continued)
• Table 40 SUMMARY OF JOINT REPLACEMENTS, IMPLANTS AND REGENERATIVE PRODUCTS BY COMPETITOR REVENUES, 2006 ($ MILLIONS)
• Figure 27 SUMMARY OF JOINT REPLACEMENTS, IMPLANTS AND REGENERATIVE PRODUCTS BY COMPETITOR REVENUES, 2006 (%)
  • MARKET SUMMARY
• Table 41 GLOBAL MARKET FOR ADVANCED ORTHOPEDICS BY PRODUCT SEGMENT, THROUGH 2012 ($ MILLIONS)
• Figure 28 GLOBAL MARKET FOR ADVANCED ORTHOPEDICS BY PRODUCT SEGMENT, THROUGH 2012 ($ MILLIONS)
  • GEOGRAPHIC MARKET ANALYSIS
• Table 42 WORLDWIDE ADVANCED ORTHOPEDIC PRODUCT REVENUE DISTRIBUTION, BY REGION, 2006 ($ BILLIONS)
• Figure 29 WORLDWIDE ADVANCED ORTHOPEDIC PRODUCT REVENUE DISTRIBUTION BY REGION, 2006 (%)
  • INDUSTRY PARTICIPANTS BY TYPE
• Table 43 ADVANCED ORTHOPEDIC TECHNOLOGY INDUSTRY PARTICIPANTS BY TYPE, 2006-2007
• COMPANY PROFILES
  • INTRODUCTION
    • AESCULAP (B BRAUN)
    • ARTHREX, INC.
    • ARTHROCARE CORP.
    • BIOMET, INC.
    • DEPUY, INC.
    • ENCORE MEDICAL CORP.
    • EXACTECH, INC.
    • GENZYME BIOSURGERY
    • ISOTIS ORTHOBIOLOGICS, INC.
    • CONMED LINVATEC
    • MEDTRONIC SOFAMOR DANEK
    • OSTEOTECH, INC.
    • SMITH & NEPHEW, PLC
    • STRYKER CORP.
    • SYNTHES, INC.
    • WRIGHT MEDICAL TECHNOLOGY, INC.
    • ZIMMER HOLDINGS, INC.
      • Zimmer Holdings, Inc. (Continued)
• APPENDIX: LEADING PRODUCT MANUFACTURERS
  • APPENDIX: LEADING PRODUCT MANUFACTURERS
    • LEADING PRODUCT MANUFACTURERS (CONTINUED)
    • LEADING PRODUCT MANUFACTURERS (CONTINUED)
    • LEADING PRODUCT MANUFACTURERS (CONTINUED)
    • LEADING PRODUCT MANUFACTURERS (CONTINUED)
    • LEADING PRODUCT MANUFACTURERS (CONTINUED)
    • LEADING PRODUCT MANUFACTURERS (CONTINUED)
• LIST OF TABLES
  • Summary Table:
  • ADVANCED ORTHOPEDIC TECHNOLOGY, IMPLANTS, AND REGENERATIVE PRODUCTS, THROUGH 2012 ($ MILLIONS)Table 1 PARTS 862-892 OF 21 CFR
  • Table 2 AMBULATORY VISITS ALL AGES, 1994 AND 2004
  • Table 3 AMBULATORY VISITS PER PERSON ALL AGES, 1994 AND 2004
  • Table 4 ANNUAL HEALTH EXPENDITURES AS A PERCENT OF GROSS DOMESTIC PRODUCT (GDP) BY COUNTRY, 2005 ESTIMATES ($ THOUSANDS)
  • Table 5 ADVANCED ORTHOPEDIC MANUFACTURING AND SUPPLY FACILITIES
  • Table 6 ADVANCED ORTHOPEDIC SALES, MARKETING AND ADMINISTRATIVE EXPENDITURES BY MANUFACTURER FOR FISCAL YEAR 2006 ($ MILLIONS)
  • Table 7 HIP REPLACEMENT: WORLDWIDE COST VARIATIONS
  • Table 8 U.S. HEALTH INSURANCE COVERAGE BY AGE GROUP (%)
  • Table 9 WORLD HEALTH ORGANIZATION RANKING OF HEALTHCARE SYSTEMS, TOP 50
  • Table 10 ESTIMATED WORLD POPULATION BY AGE GROUP, 2005-2012 (MILLIONS)
  • Table 11 ESTIMATED WORLD POPULATION, BY REGION, 2005-2012 (MILLIONS)
  • Table 12 U.S. POPULATION ESTIMATES AND PROJECTIONS BY AGE GROUP FOR THE SPECIFIC YEARS, 1900-2050 (THOUSANDS)
  • Table 13 LIFE EXPECTANCY IN THE U.S. AT BIRTH AND PROJECTIONS BY SEX, 2002-2011 (AVERAGE NUMBER OF YEARS)
  • Table 14 ESTIMATED* PREVALENCE/INCIDENCE OF CONDITIONS AFFECTING THE WORLDWIDE ORTHOPEDIC INDUSTRY
  • Table 15 U.S. AGE-ADJUSTED PERCENT DISTRIBUTION OF BODY MASS INDEX (BMI) AMONG PERSONS 18 YEARS AND OVER BY SELECTED CHARACTERISTICS, 2003
  • Table 16 PERCENT OF SMOKERS IN THE U.S. POPULATION 18 AND OLDER BY AGE AND SEX, 2003 (%)
  • Table 17 PERCENT OF U.S. ADULTS ENGAGING IN LEISURE-TIME, TRANSPORTATION-RELATED AND HOUSEHOLD-RELATED PHYSICAL ACTIVITY1 BY SELECTED CHARACTERISTICS, 2003 (%)
  • Table 18 ADVANCED ORTHOPEDIC PATENTS FILED WORLDWIDE BY YEAR, 1992-2006
  • Table 19 WORLDWIDE ADVANCED ORTHOPEDIC PATENTS BY COUNTRY THROUGH 2006
  • Table 20 ADVANCED ORTHOPEDIC PATENT INFORMATION FOR LEADING COMPANIES
  • Table 21 BONE GRAFT PRODUCTS AND MATERIALS
  • Table 22 BONE ALLOGRAFT/AUTOGRAFT PRODUCTS AND COMPETITORS
  • Table 23 BONE GROWTH STIMULATOR PRODUCTS AND COMPETITORS
  • Table 24 SYNTHETIC BONE REPLACEMENT PRODUCTS AND COMPETITORS
  • Table 25 GLOBAL BONE REPAIR AND REGERATIVE PRODUCTS MARKET FORECAST, THROUGH 2012 ($ MILLIONS)
  • Table 26 REVENUE DISTRIBUTION FOR BONE REPAIR AND REGENERATIVE PRODUCTS BY WORLD REGION, 2006
  • Table 27 SUMMARY OF BONE REPAIR AND REGENERATIVE PRODUCTS BY COMPETITOR REVENUES, 2006 ($ MILLIONS)
  • Table 28 FIXATION SYSTEMS AND OTHER SPECIALIZED DEVICES AND MARKETERS
  • Table 29 CARTILAGE AND SOFT TISSUE BIOLOGICS AND BIOMATERIALS SEGMENT
  • Table 30 CARTILAGE AND OTHER SOFT TISSUE REPAIR AND REGENERATIVE PRODUCTS MARKET, THROUGH 2012 ($ MILLIONS)
  • Table 31 WORLDWIDE DISTRIBUTION OF REVENUES FROM CARTILAGE AND OTHER SOFT TISSUE REPAIR AND REGENERATIVE PRODUCTS BY REGION, 2006 (%)
  • Table 32 SUMMARY OF CARTILAGE AND OTHER SOFT TISSUE REPAIR AND REGENERATIVE PRODUCTS BY COMPETITOR REVENUES, 2006 ($ MILLIONS)
  • Table 33 HIP REPLACEMENT PRODUCTS AND COMPETITORS
  • Table 33 (CONTINUED)
  • Table 34 KNEE REPLACEMENT PRODUCTS AND COMPETITORS
  • Table 35 SPINE REPLACEMENT PRODUCTS AND COMPETITORS
  • Table 36 OTHER EXTREMITY REPLACEMENTS, JOINT PRODUCTS AND COMPETITORS
  • Table 37 BIOLOGICAL JOINT PRODUCTS AND OTHER RELATED DEVICES
  • Table 38 GLOBAL JOINT REPLACEMENT, IMPLANT AND REGENERATIVE PRODUCT MARKET FORECASTS, THROUGH 2012 ($ MILLIONS)
  • Table 39 WORLDWIDE REVENUE DISTRIBUTION FOR JOINT REPLACEMENTS, IMPLANTS AND REGENERATIVE PRODUCTS, 2006 (%)
  • Table 40 SUMMARY OF JOINT REPLACEMENTS, IMPLANTS AND REGENERATIVE PRODUCTS BY COMPETITOR REVENUES, 2006 ($ MILLIONS)
  • Table 41 GLOBAL MARKET FOR ADVANCED ORTHOPEDICS BY PRODUCT SEGMENT, THROUGH 2012 ($ MILLIONS)
  • Table 42 WORLDWIDE ADVANCED ORTHOPEDIC PRODUCT REVENUE DISTRIBUTION, BY REGION, 2006 ($ BILLIONS)
  • Table 43 ADVANCED ORTHOPEDIC TECHNOLOGY INDUSTRY PARTICIPANTS BY TYPE, 2006-2007
• LIST OF FIGURES
  • Summary Figure:
  • ADVANCED ORTHOPEDIC TECHNOLOGY, IMPLANTS AND REGENERATIVE PRODUCTS, THROUGH 2012 ($ MILLIONS)Figure 1 STANDARD SUBMISSION FEES AND EXPENDITURES FOR DEVICE APPROVALS PER COUNTRY (U.S. DOLLARS)
  • Figure 2 ANNUAL HEALTH EXPENDITURES AS A PERCENT OF GROSS DOMESTIC PRODUCT (GDP) BY COUNTRY, 2005 ESTIMATES ($ THOUSANDS)
  • Figure 3 ADVANCED ORTHOPEDIC SALES, MARKETING AND ADMINISTRATIVE EXPENDITURES BY MANUFACTURER FOR FISCAL YEAR 2006 ($ MILLIONS)
  • Figure 4 HIP REPLACEMENT: WORLDWIDE COST VARIATIONS
  • Figure 5 U.S. HEALTH INSURANCE COVERAGE BY AGE GROUP (%)
  • Figure 6 ESTIMATED WORLD POPULATION BY AGE GROUP, 2005-2012 (MILLIONS)
  • Figure 7 ESTIMATED WORLD POPULATION BY REGION, THROUGH 2012 (MILLIONS)
  • Figure 8 U.S. POPULATION ESTIMATES AND PROJECTIONS BY AGE GROUP FOR THE SPECIFIC YEARS, 1900-2050 (THOUSANDS)
  • Figure 9 LIFE EXPECTANCY IN THE U.S. AT BIRTH AND PROJECTIONS, BY SEX, 2000-2011 (AVERAGE NUMBER OF YEARS)
  • Figure 10 ESTIMATED* PREVALENCE/INCIDENCE OF CONDITIONS AFFECTING THE WORLDWIDE ORTHOPEDIC INDUSTRY (%)
  • Figure 11 NUMBER OF U.S. HIP REPLACEMENT PROCEDURES, 2000-2006 (THOUSANDS)
  • Figure 12 NUMBER OF U.S. KNEE REPLACEMENT PROCEDURES, 2000-2006 (THOUSANDS)
  • Figure 13 NUMBER OF U.S. SPINAL FUSION PROCEDURES, 2000-2006 (THOUSANDS)
  • Figure 13 (CONTINUED)
  • Figure 14 NUMBER OF U.S. PHYSICIAN VISITS FOR ROTATOR CUFF PROBLEMS, 2000-2006 (MILLIONS)
  • Figure 15 OBESITY PERCENTAGES BY COUNTRY, 2005
  • Figure 16 ADVANCED ORTHOPEDIC PATENTS FILED WORLDWIDE BY YEAR, 1992-2006
  • Figure 17 WORLDWIDE ADVANCED ORTHOPEDIC PATENTS BY COUNTRY THROUGH 2006 (%)
  • Figure 18 ADVANCED ORTHOPEDIC PATENTS HELD BY LEADING COMPANIES
  • Figure 19 GLOBAL BONE REPAIR AND REGERATIVE PRODUCTS MARKET FORECAST 2005-2012 ($ MILLIONS)
  • Figure 20 REVENUE DISTRIBUTION FOR BONE REPAIR AND REGENERATIVE PRODUCTS BY WORLD REGION, 2006 (%)
  • Figure 21 SUMMARY OF BONE REPAIR AND REGENERATIVE PRODUCTS BY COMPETITOR REVENUES, 2006 ($ MILLIONS)
  • Figure 22 CARTILAGE AND OTHER SOFT TISSUE REPAIR AND REGENERATIVE PRODUCTS MARKET, 2005-2012 ($ MILLIONS)
  • Figure 23 WORLDWIDE DISTRIBUTION OF REVENUES FROM CARTILAGE AND OTHER SOFT TISSUE REPAIR AND REGENERATIVE PRODUCTS BY REGION, 2006 (%)
  • Figure 24 SUMMARY OF CARTILAGE AND OTHER SOFT TISSUE REPAIR AND REGENERATIVE PRODUCTS BY COMPETITOR REVENUES, 2006 (%)
  • Figure 25 GLOBAL JOINT REPLACEMENT, IMPLANT AND REGENERATIVE PRODUCT MARKET FORECASTS, THROUGH 2012 ($ MILLIONS)
  • Figure 26 WORLDWIDE REVENUE DISTRIBUTION FOR JOINT REPLACEMENTS, IMPLANTS AND REGENERATIVE PRODUCTS, 2006 (%)
  • Figure 27 SUMMARY OF JOINT REPLACEMENTS, IMPLANTS AND REGENERATIVE PRODUCTS BY COMPETITOR REVENUES, 2006 (%)
  • Figure 28 GLOBAL MARKET FOR ADVANCED ORTHOPEDICS BY PRODUCT SEGMENT, THROUGH 2012 ($ MILLIONS)
  • Figure 29 WORLDWIDE ADVANCED ORTHOPEDIC PRODUCT REVENUE DISTRIBUTION BY REGION, 2006 (%)